Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes.
about
The Impact of Precision Medicine in Diabetes: A Multidimensional Perspective.Precision diabetes: learning from monogenic diabetes.Monogenic diabetes prevalence among Polish children-Summary of 11 years-long nationwide genetic screening program.Genetic Factors of Diabetes.Population-Based Assessment of a Biomarker-Based Screening Pathway to Aid Diagnosis of Monogenic Diabetes in Young-Onset Patients.A novel mutation in the hepatocyte nuclear factor-1β gene in maturity onset diabetes of the young 5 with multiple renal cysts and pancreas hypogenesis: A case report.Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetranceJuvenile-Onset Diabetes and Congenital Cataract: "Double-Gene" Mutations Mimicking a Syndromic Diabetes Presentation.Towards a systematic nationwide screening strategy for MODY.Can Biomarkers Help Target Maturity-Onset Diabetes of the Young Genetic Testing in Antibody-Negative Diabetes?Comprehensive screening for monogenic diabetes in 89 Japanese children with insulin-requiring antibody-negative type 1 diabetes.Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry.Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial.Case Report: Identification of an HNF1B p.Arg527Gln mutation in a Maltese patient with atypical early onset diabetes and diabetic nephropathy.C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase.Tests aiding diagnosis of monogenic diabetes
P2860
Q30275284-504F4060-BAA9-4A98-B13F-E4195524BA3FQ33453490-9692018B-0845-4CB5-A06C-6A4204935D19Q38823689-BF7F25A7-D314-4CF6-AA34-D2B443B880F4Q39084940-D39C3385-109B-4AB2-87D8-DA99EA7EBD88Q41513696-F8ED1885-F246-4F66-AE61-75A4A4ACE53BQ41623705-E4688319-09C1-450C-86ED-497F3F048740Q42376064-6FC48D8C-5A93-4AFD-9432-420CE76985D3Q47112735-990C138C-E9F8-4BF7-A2C3-855A08B27B30Q48853696-95CC23F3-9B53-4BF8-8DB5-11D0A90B9656Q49885981-46581C0C-7E3C-4F31-9726-018FC9B0F226Q50205359-4A1F6825-AE1B-4E45-8D08-1EC666C82DCDQ51287966-C51B48B8-E73B-4858-A9D4-9A9B2CB9474FQ55032846-D2276A2C-19F1-4C77-B631-1CDEC5A7BD80Q55343661-A4442AF0-4B93-4662-A623-B6DE5A2A7540Q55422993-89EC3FD0-5A75-4119-94C1-180FA6B77524Q57917247-1A1E4D6C-80AD-49F4-9B17-976F7E9B484B
P2860
Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population With Monogenic Diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Systematic Population Screenin ...... ation With Monogenic Diabetes.
@en
Systematic Population Screenin ...... ation With Monogenic Diabetes.
@nl
type
label
Systematic Population Screenin ...... ation With Monogenic Diabetes.
@en
Systematic Population Screenin ...... ation With Monogenic Diabetes.
@nl
prefLabel
Systematic Population Screenin ...... ation With Monogenic Diabetes.
@en
Systematic Population Screenin ...... ation With Monogenic Diabetes.
@nl
P2093
P2860
P50
P356
P1433
P1476
Systematic Population Screenin ...... lation With Monogenic Diabetes
@en
P2093
Barbara Fraser
Beverley Shields
Bridget Knight
Christopher Hyde
Christopher Moudiotis
Julian Cox
Katherine Mallam
Kevin Colclough
Maggie Shepherd
Rebecca Smith
P2860
P304
P356
10.2337/DC16-0645
P407
P577
2016-06-06T00:00:00Z